Literature DB >> 23087431

T-helper 17 cells are associated with pathology in human schistosomiasis.

Moustapha Mbow1, Bridget M Larkin, Lynn Meurs, Linda J Wammes, Sanne E de Jong, Lucja A Labuda, Makhtar Camara, Hermelijn H Smits, Katja Polman, Tandakha N Dieye, Souleymane Mboup, Miguel J Stadecker, Maria Yazdanbakhsh.   

Abstract

BACKGROUND: Schistosome infections are often clinically silent, but some individuals develop severe pathological reactions. In several disease processes, T-helper 17 (Th17) cells have been linked to tissue injuries, while regulatory T cells (Tregs) are thought to downmodulate inflammatory reactions. We assessed whether bladder pathology in human Schistosoma haematobium infection is related to the balance of Th17 cells and Tregs. We used a murine model of Schistosoma mansoni infection to further investigate whether the peripheral profiles reflected ongoing events in tissues.
METHODS: We characterized T-helper cell subsets in the peripheral blood of children residing in a S. haematobium-endemic area and in the peripheral blood, spleen, and hepatic granulomas of S. mansoni-infected high-pathology CBA mice and low-pathology C57BL/6 mice.
RESULTS: S. haematobium-infected children with bladder pathology had a significantly higher percentage of Th17 cells than those without pathology. Moreover, the Th17/Treg ratios were significantly higher in infected children with pathology, compared with infected children without pathology. Percentages of interleukin 17-producing cells were significantly higher in spleen and granulomas of CBA mice, compared with C57BL/6 mice. This difference was also reflected in the peripheral blood.
CONCLUSIONS: This is the first study to indicate that Th17 cells may be involved in the pathogenesis of human schistosomiasis.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23087431      PMCID: PMC3571236          DOI: 10.1093/infdis/jis654

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  34 in total

1.  Alternative macrophage activation is essential for survival during schistosomiasis and downmodulates T helper 1 responses and immunopathology.

Authors:  De'Broski R Herbert; Christoph Hölscher; Markus Mohrs; Berenice Arendse; Anita Schwegmann; Magda Radwanska; Mosiuoa Leeto; Richard Kirsch; Pauline Hall; Horst Mossmann; Björn Claussen; Irmgard Förster; Frank Brombacher
Journal:  Immunity       Date:  2004-05       Impact factor: 31.745

2.  The intensity and effects of infection with Schistosoma mansoni in a rural community in northeast Brazil.

Authors:  J S Lehman; K E Mott; R H Morrow; T M Muniz; M H Boyer
Journal:  Am J Trop Med Hyg       Date:  1976-03       Impact factor: 2.345

3.  CD25+CD4+ cells contribute to Th2 polarization during helminth infection by suppressing Th1 response development.

Authors:  Amy S McKee; Edward J Pearce
Journal:  J Immunol       Date:  2004-07-15       Impact factor: 5.422

4.  The pathogenesis of schistosomiasis is controlled by cooperating IL-10-producing innate effector and regulatory T cells.

Authors:  Matthias Hesse; Ciriaco A Piccirillo; Yasmine Belkaid; Jeannette Prufer; Margaret Mentink-Kane; Mary Leusink; Allen W Cheever; Ethan M Shevach; Thomas A Wynn
Journal:  J Immunol       Date:  2004-03-01       Impact factor: 5.422

5.  Immunity after treatment of human schistosomiasis mansoni. I. Study design, pretreatment observations and the results of treatment.

Authors:  A E Butterworth; P R Dalton; D W Dunne; M Mugambi; J H Ouma; B A Richardson; T K Siongok; R F Sturrock
Journal:  Trans R Soc Trop Med Hyg       Date:  1984       Impact factor: 2.184

6.  Suppression of immune induction of collagen-induced arthritis in IL-17-deficient mice.

Authors:  Susumu Nakae; Aya Nambu; Katsuko Sudo; Yoichiro Iwakura
Journal:  J Immunol       Date:  2003-12-01       Impact factor: 5.422

7.  Association of type 2 cytokines with hepatic fibrosis in human Schistosoma mansoni infection.

Authors:  Amélia Ribeiro de Jesus; Andréa Magalhães; Delfin Gonzalez Miranda; Roberval Gonzalez Miranda; Maria Ilma Araújo; Adriana Almeida de Jesus; Angela Silva; Luciana B Santana; Edward Pearce; Edgar M Carvalho
Journal:  Infect Immun       Date:  2004-06       Impact factor: 3.441

Review 8.  Immunopathogenesis of schistosomiasis.

Authors:  Thomas A Wynn; Robert W Thompson; Allen W Cheever; Margaret M Mentink-Kane
Journal:  Immunol Rev       Date:  2004-10       Impact factor: 12.988

9.  Assessing the delivery of neutrophils to tissues in neutropenia.

Authors:  D G Wright; A I Meierovics; J M Foxley
Journal:  Blood       Date:  1986-04       Impact factor: 22.113

Review 10.  Schistosomiasis: host-pathogen biology.

Authors:  K S Warren
Journal:  Rev Infect Dis       Date:  1982 Jul-Aug
View more
  47 in total

1.  Changes in immunological profile as a function of urbanization and lifestyle.

Authors:  Moustapha Mbow; Sanne E de Jong; Lynn Meurs; Souleymane Mboup; Tandakha Ndiaye Dieye; Katja Polman; Maria Yazdanbakhsh
Journal:  Immunology       Date:  2014-12       Impact factor: 7.397

2.  Gene Expression Differences in Host Response to Schistosoma haematobium Infection.

Authors:  Kathryn M Dupnik; Mary Juliet Reust; Kaitlin M Vick; Benjamin Yao; Donald Miyaye; Eric Lyimo; Crispin Mukerebe; Julius Mngara; Samuel E Kalluvya; Claudia J de Dood; Paul L A M Corstjens; Govert J van Dam; Tuo Zhang; Jenny Xiang; Myung Hee Lee; Jennifer A Downs
Journal:  Infect Immun       Date:  2018-12-19       Impact factor: 3.441

3.  Interleukin 1 (IL-1)- and IL-23-mediated expansion of filarial antigen-specific Th17 and Th22 cells in filarial lymphedema.

Authors:  R Anuradha; P Jovvian George; V Chandrasekaran; P Paul Kumaran; Thomas B Nutman; Subash Babu
Journal:  Clin Vaccine Immunol       Date:  2014-05-07

Review 4.  Induction and regulation of pathogenic Th17 cell responses in schistosomiasis.

Authors:  Bridget M Larkin; Patrick M Smith; Holly E Ponichtera; Mara G Shainheit; Laura I Rutitzky; Miguel J Stadecker
Journal:  Semin Immunopathol       Date:  2012-10-25       Impact factor: 9.623

5.  Dendritic cell expression of the C-type lectin receptor CD209a: A novel innate parasite-sensing mechanism inducing Th17 cells that drive severe immunopathology in murine schistosome infection.

Authors:  Holly E Ponichtera; Miguel J Stadecker
Journal:  Exp Parasitol       Date:  2015-04-23       Impact factor: 2.011

6.  CD209a expression on dendritic cells is critical for the development of pathogenic Th17 cell responses in murine schistosomiasis.

Authors:  Holly E Ponichtera; Mara G Shainheit; Beiyun C Liu; Raktima Raychowdhury; Bridget M Larkin; Joanne M Russo; D Brenda Salantes; Chao-Qiang Lai; Laurence D Parnell; Tae J Yun; Cheolho Cheong; Stephen C Bunnell; Nir Hacohen; Miguel J Stadecker
Journal:  J Immunol       Date:  2014-04-11       Impact factor: 5.422

Review 7.  Helminth infection in populations undergoing epidemiological transition: a friend or foe?

Authors:  Aprilianto Eddy Wiria; Yenny Djuardi; Taniawati Supali; Erliyani Sartono; Maria Yazdanbakhsh
Journal:  Semin Immunopathol       Date:  2012-11-06       Impact factor: 9.623

8.  Phosphorylated STAT3 and PD-1 regulate IL-17 production and IL-23 receptor expression in Mycobacterium tuberculosis infection.

Authors:  Anuradha Bandaru; Kamakshi P Devalraju; Padmaja Paidipally; Rohan Dhiman; Sambasivan Venkatasubramanian; Peter F Barnes; Ramakrishna Vankayalapati; Vijayalakshmi Valluri
Journal:  Eur J Immunol       Date:  2014-04-23       Impact factor: 5.532

9.  The schistosoma granuloma: friend or foe?

Authors:  Emily Hams; Gabriella Aviello; Padraic G Fallon
Journal:  Front Immunol       Date:  2013-04-15       Impact factor: 7.561

10.  Alterations in peripheral blood B cell subsets and dynamics of B cell responses during human schistosomiasis.

Authors:  Lucja A Labuda; Ulysse Ateba-Ngoa; Eliane Ngoune Feugap; Jorn J Heeringa; Luciën E P M van der Vlugt; Regina B A Pires; Ludovic Mewono; Peter G Kremsner; Menno C van Zelm; Ayola A Adegnika; Maria Yazdanbakhsh; Hermelijn H Smits
Journal:  PLoS Negl Trop Dis       Date:  2013-03-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.